Companies›Information Technology›Information Technology›IT - Software

HINDUSTAN BIO SCIENCES LTD.

Information Technology › IT - Software
₹6.80
at close · 28 Oct 2026
▲ 0.00 (+0.00%)

Latest filings

Next results: Sat, 31 Oct · Financial Results
  1. Board meeting to approve September 2026 quarterly results · Results
  2. RTA confirms no demat or remat requests in Q2 FY27 · Compliance
  3. AGM clears capital reduction scheme and key resolutions · Board & Shareholder Meetings
All filings ↓
Ask Nexa about HINDUSTAN BIO SCIENCES LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

A IT - Software company listed on BSE, reporting revenue of ₹1 Cr over the trailing twelve months.

Market Cap
₹7 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
-6.5%▼
Revenue 5y CAGR
PAT — · EBITDA —
Quality
-1.8%·
ROCE (5y median)
ROE -5.4% (5y median) · margin -7.9%
Leverage
2.84·
Debt / Equity · high
Net debt ₹2.22 Cr
Revenue FY21→FY26
0.7×▼
Margin +80.4 pts
₹1 Cr → ₹1 Cr
Moves on a normal day
2.82%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 43 Software Products peersBar = share of peers beaten · tick = industry median · latest reported figures
P/B#34/38
ROCE#32/40
ROE#34/38
Debt / Equity#38/38
Revenue growth#31/33
Profit growth#35/41

Scorecard

Measured from the filed financials, judged against its Software Products peers · as of FY26 — not investment advice

Strengths
Nothing stands out in the filed numbers.
Concerns
Revenue shrinking over 5 years (−7% a year)
Negative returns on capital — −1.8% (5-year median)
#32 of 40 in Software Products on the latest reported figures · up from −46.5% in FY21
Carries more debt than its peers — 2.84× equity
higher than 100% of its 38 Software Products peers

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from HINDUSTAN BIO SCIENCES LTD.'s filed financials and exchange disclosures

What does HINDUSTAN BIO SCIENCES LTD. do?

HINDUSTAN BIO SCIENCES LTD. is a IT - Software company listed on BSE.

Is HINDUSTAN BIO SCIENCES LTD. profitable?

No. Over the trailing twelve months HINDUSTAN BIO SCIENCES LTD. reported a net loss of ₹0.08 Cr on revenue of ₹0.70 Cr.

Does HINDUSTAN BIO SCIENCES LTD. pay a dividend?

Not in the latest reported year — HINDUSTAN BIO SCIENCES LTD.'s dividend payout for FY26 was nil.

Is HINDUSTAN BIO SCIENCES LTD. debt-free?

No. It reported borrowings of ₹2.35 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹2.22 Cr after cash. Debt stands at 2.84× equity. That is higher than 100% of its 38 Software Products peers.

How much does the HINDUSTAN BIO SCIENCES LTD. share price move in a day?

On a typical session HINDUSTAN BIO SCIENCES LTD. moves 2.82% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

When are HINDUSTAN BIO SCIENCES LTD.'s next results?

Financial Results on Sat, 31 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track HINDUSTAN BIO SCIENCES LTD.'s announcements?

Every NSE and BSE filing by HINDUSTAN BIO SCIENCES LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.